Skip to main content
. 2024 Jan 27;25(3):1582. doi: 10.3390/ijms25031582
PRAME Preferentially expressed Antigen in Melanoma
CT130 Cancer Testis Antigen 130
MAPE Melanoma Antigen Preferentially Expressed in tumours
OIP-4 Opa-interacting protein 4
CTA Cancer/Testis Antigen
AML Acute Myeloid Leukaemia
LRR Leucine-Rich Repeats
RA Retinoic Acid
MITF Microphthalmia Transcription Factor
NMSC Non-Melanoma Skin Cancer
MCC Merkel Cell Carcinoma
DEJ Dermal–Epidermal Junction
SCC Squamous Cell Carcinoma
BCC Basal Cell Carcinoma
SUM Subungual Melanoma
AM Acral Melanoma
SMP Subungual Melanocytic Proliferation
AST Atypical Spitz Tumour
CCS Clear Cell Sarcoma
RBT Retinoid-Based Therapy
CAR-T Chimeric Antigen Receptor T cell